A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis

Overview of attention for article published in American Journal of Gastroenterology, August 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 7 news outlets

twitter: 16 X users

Readers on

mendeley: 23 Mendeley

So far, Altmetric has seen 21 X posts from 16 X users, with an upper bound of 107,376 followers.

RT @HighTideThera: JUST RELEASED: The results of our Phase 2 study of HTD1801 in adults with primary sclerosing cholangitis (#PSC) have bee…

JUST RELEASED: The results of our Phase 2 study of HTD1801 in adults with primary sclerosing cholangitis (#PSC) have been published in @AmJGastro. The study met its primary & secondary endpoints, incl. significantly reduced serum ALP levels. https:/…

RT @AmJGastro: 🎙️ Author Podcast — A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primar…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 17 additional X posts.